A series of in vitro experiments demonstrated that the demethylation systems guided by sgRNA2 and sgRNA5 could promote transcriptional activation and BRD7 expression by reducing its methylation, inhibiting the proliferation, migration, invasion of NPC cells and tumour growth in vivo. This evidence concerns the gene BRD7 and nasopharyngeal carcinoma.